OSCR:NYSE, Oscar Health, Inc.
OSCR stock overview
Oscar Health, Inc. (OSCR:NYSE) closed at $24.73 on November 20, 2026,
down 5.50% on the day.
The stock trades 35.8% below its 52-week high of $38.50
and 131.3% above its 52-week low of $10.69.
Over the past year, it gained 83.5%.
Oscar Health, Inc. is part of the Financials sector.
Key figures
- Price
- $24.73
- Day change
- -5.50%
- Volume
- 6,600,079
- Average volume
- 5,275,981
- Market cap
- 7B+
- 52-week range
- $10.69 – $38.50
- 50-day average
- $31.71
- 200-day average
- $24.73
Price action over the past year
In 252 trading sessions since November 20, 2025, OSCR closed higher on 126 days (50%).
Its best day was November 24, 2025 (+22.33%) and its worst was August 6, 2026 (-11.86%).
The stock moved 10% or more in a single session 10 times.
It opened at least 5% above the previous day's high 5 times.
Recent signals
OSCR news
-
Nov 20, 2026:
OSCR or ZURVY: Which Is the Better Value Stock Right Now?
-
Nov 19, 2026:
Oscar Health (OSCR) Stock May Still Be A Bargain Despite Raised Outlook
-
Nov 18, 2026:
Hy-Vee Health with Oscar Expands Across Iowa, Into Kansas City and Omaha for 2027 Open Enrollment
-
Nov 18, 2026:
Best Growth Stocks to Buy for November 18th
-
Nov 17, 2026:
Oscar Highlights Tailored New Health Products in Florida for 2027 Open Enrollment
-
Nov 17, 2026:
Oscar Highlights Tailored New Health Products in Texas for 2027 Open Enrollment
-
Nov 17, 2026:
Aon Closes $17 Billion USI Deal, Expanding U.S. Market Reach
-
Nov 16, 2026:
Oscar Health Expands its Board of Directors with Technology, Healthcare and Product Innovators to Advance Consumer Healthcare
About Oscar Health, Inc.
Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, family, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services.
Similar stocks
Find more stocks like OSCR with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.